MyMonitor.ai
Skin diagnosis in 5 seconds
Philadelphia, Pennsylvania, US
MyMonitor.ai is an AI-powered dermatology and clinical research platform that utilizes multispectral imaging technology for melanin-aware lesion detection. It processes skin analysis in under 5 seconds and achieves high agreement with board-certified dermatologists.
Source: HealthTechAlpha
HealthTechAlpha provided this information. To learn more and get deep data on all digital health companies, please visit them here.
Visit HealthTechAlpha →Problem Statement
Addressing equity gaps in diagnostics and clinical research for people with skin of color, improving dermatological diagnosis speed and accuracy, and enhancing diverse clinical trial enrollment.
Core Technology
Multispectral imaging technology for melanin-aware lesion detection
Key Differentiators
Processes skin analysis in under 5 seconds; Achieves κ > 0.90 agreement with board-certified dermatologists; Achieves 60% faster diagnosis compared to standard dermatological assessment; Clinical pilots achieved 40% more diverse enrollment in clinical trials
Clinical Focus
Lesion Detection; Clinical Research
Company Info
- Business Model
- SaaS
- Website
- mymonitor.ai
Categories
Disease Areas
Technologies
Clinical & IP
Clinical Validation
κ > 0.90 agreement with board-certified dermatologists; 60% faster diagnosis; melanin-compensated detection validated across diverse skin populations; live clinical pilots with Clinical Research of Philadelphia.
MedStartr Index Score
?What do you think of MyMonitor.ai?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.